• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Urinary kallikrein levels during pregnancy].

作者信息

Saitoh M, Munakata S, Sada I, Tanaka S, Ooishi T, Nakamura Y, Nomura Y, Shinagawa S

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1985 Apr;37(4):539-46.

PMID:3845954
Abstract

Whether to determine the urinary kallikrein (UKK) levels in the second trimester of pregnancy is valuable in predicting of gestosis, especially of hypertension, was studied using samples of urine obtained from 500 cases of pregnant women without gestosis, 50 pregnant women with gestosis and 50 cases of pregnancy with a variety of complications other than gestosis. The main results obtained were as follows: In normal pregnancy, UKK levels elevated with pregnancy for a peak in the first to the second trimester of pregnancy, tapering off thereafter. The UKK level was significantly lower in 20 pregnant women with gestosis especially in hypertensive type than in pregnant women without gestosis (p less than 0.001). Pregnant women with normal blood pressure who suffered no gestosis and had an extremely low UKK level, accounted for 9.8% of all pregnant women studied. This figure includes a large number of those who were in a high risk group for the onset of gestosis. From these findings, UKK was considered to be useful as one of the factors used in predicting the onset of hypertension in association with gestosis and we are now studying pregnant women in the 20th and 30th week of pregnancy in more detail.

摘要

相似文献

1
[Urinary kallikrein levels during pregnancy].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Apr;37(4):539-46.
2
[Clinical value of urinary kallikrein determination in obstetrics].[尿激肽释放酶测定在产科中的临床价值]
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Feb;38(2):187-94.
3
Urinary kallikrein in normal and hypertensive pregnancies.正常妊娠和高血压妊娠中的尿激肽释放酶
Perspect Nephrol Hypertens. 1976;5:329-38.
4
Urinary kallikrein excretion in normal and hypertensive pregnancy at term.足月正常妊娠和高血压妊娠时的尿激肽释放酶排泄量。
Ann Clin Res. 1986;18(4):208-10.
5
[Urinary kallikrein quantity and activity of normal pregnant women and toxemia patients in third trimester].[正常孕妇及妊娠晚期毒血症患者尿激肽释放酶的量与活性]
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Feb;38(2):177-80.
6
Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis.妊娠高血压综合征孕妇母体血浆、脐带血和羊水当中瘦素与神经肽Y的浓度
Arch Immunol Ther Exp (Warsz). 1998;46(5):311-6.
7
[Kallikrein (urine) in pregnancy-induced hypertension].
Geburtshilfe Frauenheilkd. 1995 Oct;55(10):580-2. doi: 10.1055/s-2007-1023528.
8
Hypocalciuria in preeclampsia.
N Engl J Med. 1987 Mar 19;316(12):715-8. doi: 10.1056/NEJM198703193161204.
9
Variation of urinary kallikrein excretion during pregnancy and the effects of hypertension.孕期尿激肽释放酶排泄量的变化及高血压的影响。
Adv Exp Med Biol. 1979;120B:637-43.
10
[Urinary kallikrein quantity and activity in normal pregnant women in the third trimester].[孕晚期正常孕妇尿激肽释放酶的量与活性]
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jul;37(7):1156-60.